MONALIZUMAB

UNII:	3ZXZ2V0588
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	MONALIZUMAB
GSRS Full Record:	3ZXZ2V0588 i

1228763-95-8
Anti-NKG2A
HUMZ270
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS KLRC1 (KILLER CELL LECTIN-LIKE RECEPTOR SUBFAMILY C MEMBER 1, NKG2-A, NKG2A, CD159A, CD94)), HUMANIZED MONOCLONAL ANTIBODY
IPH-2201
IPH-2201 (ANTI-NKG2A)
IPH2201
Immunoglobulin G4, anti-(human NKG2A/CD94 receptor) (human-mouse monoclonal humZ270 heavy chain), disulfide with human-mouse monoclonal humZ270 light chain, dimer
Immunoglobulin G4-kappa, anti-[Homo sapiens KLRC1 (killer cell lectin-like receptor subfamily C member 1, NKG2-A, NKG2A, CD159a, CD94)], humanized monoclonal antibody; gamma4 heavy chain (1-452) [humanized VH (Homo sapiens IGHV1-18*01 (89.80%)-(IGHD)-IGHJ2*01 R120>Q(117), L123>T(130))[8.8.18](1-125)), IGHG4*01 (CH1 (126-223), hinge S10>P (233) (224-235), CH2 (236-345), CH3 (346-450), CHS (451-452))(126-452)],(139-214’)-disulfide with kappa light chain (1’-214’) [humanized V-KAPPA (Homo sapiens IGKV1-39*01 (87.40%) – IGKJ4*01) [6.3.9] (1’-107’)-Homo sapiens IGKC*01, Km3 (108’-214’)]; dimer (231-231’’: 234-234’’)-bisdisulfide
MONALIZUMAB [USAN]
Monalizumab
Monalizumab [WHO-DD]
NN-8765
NN8765
NN8765-3658
NNC0141-0000-0100
NNC0141-0100
monalizumab [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

MONALIZUMAB

Synonyms and Mappings

Resources